Literature DB >> 15650448

Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tl-chloride.

Kaj Ljunggren1, Xiaowei Liu, Kjell Erlandsson, Michael Ljungberg, Leif Salford, Sven-Erik Strand.   

Abstract

Studies on animals with gliomas inoculated in the brain and treated with intratumoral injections of 201Tl-chloride have previously shown very promising results, with a survival several weeks longer than controls. Total regression was found in some animals, and necrosis was found in all the 201Tl-treated brain tumors. This study was undertaken to estimate the absorbed dose and dose distribution to the tumor based on the localization and clearance properties obtained from images with two high-resolution imaging techniques; pinhole single photon emission computed tomography (SPECT) and beta-camera. The images from the beta-camera were used to calculate the absorbed dose rate, using an in-house-developed, voxel-based Monte Carlo program, based on the EGS4 package. To evaluate the effects of different beta-particle energies on the absorbed dose rate distribution, simulations of medium- and high-energy electrons were conducted. Dose-volume histograms from these simulations show that the energy absorption is very locally distributed for 201Tl and medium energy, whereas high-energy beta emitters show a broader dose-volume distribution. The calculated total absorbed dose of 2-8 Gy in the tumor seems to be relativity low when considering the therapeutic effect that was seen. Further investigations, to determine the cause of the high therapeutic efficacy, are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15650448     DOI: 10.1089/cbr.2004.19.562

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  3 in total

1.  MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.

Authors:  Yuni K Dewaraja; Eric C Frey; George Sgouros; A Bertrand Brill; Peter Roberson; Pat B Zanzonico; Michael Ljungberg
Journal:  J Nucl Med       Date:  2012-06-28       Impact factor: 10.057

2.  188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas.

Authors:  E Allard; F Hindre; C Passirani; L Lemaire; N Lepareur; N Noiret; P Menei; J-P Benoit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

3.  Mutant sodium channel for tumor therapy.

Authors:  Bakhos A Tannous; Adam P Christensen; Lisa Pike; Thomas Wurdinger; Katherine F Perry; Okay Saydam; Andreas H Jacobs; Jaime García-Añoveros; Ralph Weissleder; Miguel Sena-Esteves; David P Corey; Xandra O Breakefield
Journal:  Mol Ther       Date:  2009-03-03       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.